Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
140.53
-3.46 (-2.40%)
At close: Dec 9, 2025, 4:00 PM EST
140.81
+0.28 (0.20%)
After-hours: Dec 9, 2025, 7:33 PM EST
Inspire Medical Systems Market Cap
Inspire Medical Systems has a market cap or net worth of $4.08 billion as of December 9, 2025. Its market cap has decreased by -26.82% in one year.
Market Cap
4.08B
Enterprise Value
3.79B
1-Year Change
-26.82%
Ranking
Category
Stock Price
$140.53
Market Cap Chart
Since May 3, 2018, Inspire Medical Systems's market cap has increased from $505.61M to $4.08B, an increase of 707.59%. That is a compound annual growth rate of 31.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 4.08B | -26.50% |
| Dec 31, 2024 | 5.56B | -7.51% |
| Dec 29, 2023 | 6.01B | -17.47% |
| Dec 30, 2022 | 7.28B | 15.62% |
| Dec 31, 2021 | 6.29B | 24.23% |
| Dec 31, 2020 | 5.07B | 191.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 879.46B |
| Johnson & Johnson | 481.76B |
| AbbVie | 394.11B |
| UnitedHealth Group | 293.13B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 240.48B |
| Thermo Fisher Scientific | 211.55B |